NEWAMSTERDAM PHARMA CO NV (NAMS) Stock Analyst Ratings
NASDAQ:NAMS - Nasdaq - NL00150012L7 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to NAMS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.73. This target is 87.69% above the current price.
NAMS was analyzed by 17 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about NAMS.
In the previous month the buy percentage consensus was at a similar level.
NAMS was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-11 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-12-05 | Needham | Reiterate | Buy -> Buy |
| 2024-11-21 | Needham | Reiterate | Buy -> Buy |
| 2024-11-11 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-09-23 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-28 | Needham | Initiate | Buy |
| 2024-07-30 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-06-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-05-15 | TD Cowen | Initiate | Buy |
| 2024-03-14 | ScotiaBank | Initiate | Sector Outperform -> Sector Outperform |
| 2024-03-13 | ScotiaBank | Initiate | Sector Outperform |
| 2024-02-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-18 | Guggenheim | Initiate | Buy |
| 2024-01-16 | Piper Sandler | Initiate | Overweight |
| 2023-10-30 | RBC Capital | Initiate | Outperform |
| 2023-04-03 | Credit Suisse | Maintains | Outperform |
| 2023-01-06 | Credit Suisse | Initiate | Outperform |
| 2022-12-20 | SVB Leerink | Initiate | Outperform |
| 2022-12-19 | William Blair | Initiate | Outperform |
| 2022-12-19 | Jefferies | Initiate | Buy |